Company News
OraSure Stock Up 4.1% on FDA Clearance
OraSure Technologies' shares jumped 4.1% in pre‑market trading after FDA cleared its at‑home urine collection kit for STI testing.
The cleared Colli‑Pee Dx kit, paired with Roche’s cobas 5800/6800/880
